title: Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.
authors.affiliation: Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, McGill University, Montreal, QC, Canada. allan.sniderman@muhc.mcgill.ca
authors.forename: A D
authors.initials: AD
authors.lastname: Sniderman
authors.forename: C D
authors.initials: CD
authors.lastname: Furberg
authors.forename: A
authors.initials: A
authors.lastname: Keech
authors.forename: J E
authors.initials: JE
authors.lastname: Roeters van Lennep
authors.forename: J
authors.initials: J
authors.lastname: Frohlich
authors.forename: I
authors.initials: I
authors.lastname: Jungner
authors.forename: G
authors.initials: G
authors.lastname: Walldius
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001055:Apolipoproteins B / Q000097:blood*; D002784:Cholesterol / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D000924:Anticholesteremic Agents; D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol